Part of Addex Therapeutics Ltd., Addex Pharma SA is a company headquartered in Switzerland that discovers and develops allosteric modulators for human health.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Abbott Healthcare Products BV, part of Abbott Laboratories, is a company headquartered in Weesp, the Netherlands, that manufactures and distributes pharmaceuticals.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Fidia SpA designs, produces and distributes integrated milling systems, which is applied in the manufacturing of molds and dies for automotive industry and in aerospace field. It also provide solutions for the complete milling process, from the definition of the machining program to the finished product. The company was founded by Giuseppe Morfino in 1974 and is headquartered in San Mauro Torinese, Italy.

Aegis Sciences Corp. engages in provision of forensic toxicology and consulting laboratory services. It offers Paincomp, Interact RX, Acurise ID, pre natal testing, sports testing, and Pharmacogenetic testing. The company was founded by David L. Black in 1990 and is headquartered in Nashville, TN.

AMRI (Albany Molecular Research Inc.) is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded over 27 years ago, AMRI operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. AMRI has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Co., Takeda, Genentech, Bristol-Myers Squibb Co. and GE.

D&A Pharma develops and manufactures pharmaceutical products.

Columbia University provides a hub for entrepreneurship-related information and programming.

Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Rottapharm’s long history of success began in 1961 with the creation of a small laboratory of independent research. From then on, the company has always invested on research, innovation, development and distribution on a world scale of new products mainly in the field of pharmaceutics and, in the following years, also in the fields of parapharmaceutics and nutraceutics. After acquiring the German multinational Madaus Pharma, the Group is currently one the most important pharmaceutical companies in Italy and is also present in over 85 countries worldwide.

BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 55 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world. “Caring for your Health” is the Group’s motto, and strategic areas are Innovation, Internationalisation and Quality. Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D programme. Key focus areas for the Group are the neurosciences and cardiovascular. BIAL has launched eslicarbazepine acetate, an epilepsy drug, already available in the US and in several European countries. BIAL has also developed a Parkinson’s disease compound, opicapone, also commercialized in Europe. The company expects to introduce new medicines to the market over the next few years, strengthening its international presence.

Eolas Therapeutics, Inc., a Delaware Corp based in Carlsbad, CA, is a therapeutic development company committed to treating the disease of addiction. Their lead program is a first-in-class compound to treat nicotine and cocaine addiction. Core team members are award-winning scientists considered leaders in the field of addiction, and have extensive experience in drug development.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”